Regulation of epidermal growth factor receptor signaling in triple-negative breast cancer

被引：0
|
作者：
Kappler, Christiana S.
Smith, Ericka L.
Ethier, Stephen
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4596
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Mutations in the Epidermal Growth Factor Receptor (EGFR) gene in triple-negative breast cancer: analysis by pyrosequencing in a series of 60 cases
    Carrera, R.
    Blanzquez, C.
    Escoda, M-R
    Saez, E.
    Palacio, L.
    Dalmau, E.
    Ramos, M-C
    Vazquez, J-A
    Andreu, F. J.
    VIRCHOWS ARCHIV, 2014, 465 : S324 - S324
  • [22] Wnt signaling in triple-negative breast cancer
    Pohl, SO-G
    Brook, N.
    Agostino, M.
    Arfuso, F.
    Kumar, A. P.
    Dharmarajan, A.
    ONCOGENESIS, 2017, 6 : e310 - e310
  • [23] Wnt signaling in triple-negative breast cancer
    SÖ-G Pohl
    N Brook
    M Agostino
    F Arfuso
    A P Kumar
    A Dharmarajan
    Oncogenesis, 2017, 6 : e310 - e310
  • [24] Effect of mTOR inhibition on sensitivity of triple-negative breast cancer cells to epidermal growth factor inhibition
    Liu, T.
    Yacoub, R.
    Graham, T.
    Yang, L.
    Tighiouart, M.
    O'Regan, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis
    A Paul
    S Gunewardena
    S R Stecklein
    B Saha
    N Parelkar
    M Danley
    G Rajendran
    P Home
    S Ray
    I Jokar
    G A Vielhauer
    R A Jensen
    O Tawfik
    S Paul
    Cell Death & Differentiation, 2014, 21 : 1469 - 1481
  • [26] PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis
    Paul, A.
    Gunewardena, S.
    Stecklein, S. R.
    Saha, B.
    Parelkar, N.
    Danley, M.
    Rajendran, G.
    Home, P.
    Ray, S.
    Jokar, I.
    Vielhauer, G. A.
    Jensen, R. A.
    Tawfik, O.
    Paul, S.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1469 - 1481
  • [27] Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells
    Oh, Sunhwa
    Kim, Hyungjoo
    Nam, KeeSoo
    Shin, Incheol
    BMB REPORTS, 2017, 50 (03) : 132 - 137
  • [28] Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor
    Greish, Khaled
    Nehoff, Hayley
    Bahman, Fatemah
    Pritchard, Tara
    Taurin, Sebastien
    JOURNAL OF DRUG TARGETING, 2019, 27 (08) : 903 - 916
  • [29] Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers
    Levva, Sofia
    Kotoula, Vassiliki
    Kostopoulos, Ioannis
    Manousou, Kyriaki
    Papadimitriou, Christos
    Papadopoulou, Kyriaki
    Lakis, Sotiris
    Koukoulias, Kyriakos
    Karavasilis, Vasilios
    Pentheroudakis, George
    Balassi, Eufemia
    Zagouri, Flora
    Kaklamanos, Ioannis G.
    Pectasides, Dimitrios
    Razis, Evangelia
    Aravantinos, Gerasimos
    Papakostas, Pavlos
    Bafaloukos, Dimitrios
    Rallis, Grigorios
    Gogas, Helen
    Fountzilas, George
    CANCER GENOMICS & PROTEOMICS, 2017, 14 (03) : 181 - 195
  • [30] Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer (vol 13, pg 1356, 2014)
    Brand, Toni M.
    Iida, Mari
    Dunn, Emily F.
    Luthar, Neha
    Kostopoulos, Kellie T.
    Corrigan, Kelsey L.
    Wleklinski, Matthew J.
    Yang, David
    Wisinski, Kari B.
    Salgia, Ravi
    Wheeler, Deric L.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) : 868 - 868
12345